Episode #27: Life-Changing Brain–Computer Interface Technology
Tech Optimist Podcast — Tech, Entrepreneurship, and Innovation
Explore the frontiers of medical technology in this episode of the Tech Optimist, as Alumni Ventures’ Managing Partner Ludwig Pierre Schulze sits down with Michael Mager, CEO and Co-Founder of Precision Neuroscience. They delve into the revolutionary development of brain-computer interfaces that could dramatically change lives for those with neurological conditions. Michael shares insights into Precision Neuroscience’s pioneering technology, which includes a minimally invasive method for integrating advanced computing directly with brain activity. This conversation highlights how their work is pushing the boundaries of medical science and opening new possibilities for restoring function and enhancing life quality for people affected by paralysis, stroke, and other serious conditions.
Episode #27: Life-Changing Brain–Computer Interface Technology
See video policy below.
In this episode, join Ludwig Pierre Schulze, Managing Partner at Alumni Ventures, as he engages in a captivating conversation with Michael Mager, CEO and Co-Founder of Precision Neuroscience. Discover the groundbreaking advancements in brain-computer interfaces that promise to revolutionize the lives of those with neurological conditions.
Watch Time ~38 minutes
The show is produced by Alumni Ventures, which has been recognized as a “Top 20 Venture Firm” by CB Insights (’24) and as the “#1 Most Active Venture Firm in the US” by Pitchbook (’22 & ’23).
READ THE FULL EPISODE TRANSCRIPT
Creators and Guests
HOST
Ludwig Pierre Schulze
Managing Partner at Alumni Ventures
Ludwig has been on all sides of venture — as an entrepreneur, corporate buyer of ventures, and venture capitalist. Before Alumni Ventures, he experienced the daily realities of entrepreneurship as Founder and CEO of a mobile payments venture that served over 12 million people. Earlier, at a Fortune 100 telecommunications manufacturer (Nokia), he held general manager and business development roles that included investing in and acquiring venture-backed businesses. His first experience in venture capital was with an $800 million global fund that focused on enterprise and mobile software both before and after the dot.com crash. Ludwig began his career as a strategy consultant with the Boston Consulting Group. He has a BA from Brown University and an MBA from Columbia.
GUEST
Michael Mager
Co-founder and CEO Precision Neuroscience
Michael Mager is the Co-Founder and CEO of Precision Neuroscience. Precision aims to provide breakthrough treatments through Brain-Computer Interfaces (BCI) for the one billion patients worldwide suffering from neurological illnesses.
To Learn More
Click the logos below for more information.
Important Disclosure Information
The Tech Optimist Podcast is for informational purposes only. It is not personalized advice and is neither an offer to sell, nor a solicitation of an offer to purchase, any security. Such offers are made only to eligible investors, pursuant to the formal offering documents of appropriate investment funds. Please consult with your advisors before making any investment with Alumni Ventures. For more information, please see here.
One or more investment funds affiliated with AV may have invested, or may in the future invest, in some of the companies featured on the Podcast. This circumstance constitutes a conflict of interest. Any testimonials or endorsements regarding AV on the Podcast are made without compensation but the providers may in some cases have a relationship with AV from which they benefit. All views expressed on the Podcast are the speaker’s own. Any testimonials or endorsements expressed on the Podcast do not represent the experience of all investors or companies with which AV invests or does business.
The Podcast includes forward-looking statements, generally consisting of any statement pertaining to any issue other than historical fact, including without limitation predictions, financial projections, the anticipated results of the execution of any plan or strategy, the expectation or belief of the speaker, or other events or circumstances to exist in the future. Forward looking statements are not representations of actual fact, depend on certain assumptions that may not be realized, and are not guaranteed to occur. Any forward- looking statements included in this communication speak only as of the date of the communication. AV and its affiliates disclaim any obligation to update, amend, or alter such forward-looking statements whether due to subsequent events, new information, or otherwise.